Cargando…

Nifurtimox plus Eflornithine for Late-Stage Sleeping Sickness in Uganda: A Case Series

BACKGROUND: We report efficacy and safety outcomes from a prospective case series of 31 late-stage T.b. gambiense sleeping sickness (Human African Trypanosomiasis, HAT) patients treated with a combination of nifurtimox and eflornithine (N+E) in Yumbe, northwest Uganda in 2002–2003, following on a pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Checchi, Francesco, Piola, Patrice, Ayikoru, Harriet, Thomas, Florence, Legros, Dominique, Priotto, Gerardo
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2007
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2100371/ https://www.ncbi.nlm.nih.gov/pubmed/18060083 http://dx.doi.org/10.1371/journal.pntd.0000064

Ejemplares similares

Three Drug Combinations for Late-Stage Trypanosoma brucei gambiense Sleeping Sickness: A Randomized Clinical Trial in Uganda
por: Priotto, Gerardo, et al.
Publicado: (2006)

In-Hospital Safety in Field Conditions of Nifurtimox Eflornithine Combination Therapy (NECT) for T. b. gambiense Sleeping Sickness
por: Schmid, Caecilia, et al.
Publicado: (2012)

Efficacy and Toxicity of Fexinidazole and Nifurtimox Plus Eflornithine in the Treatment of African Trypanosomiasis: A Systematic Review
por: Hidalgo, Jessica, et al.
Publicado: (2021)

720. Efficacy of Nifurtimox + Eflornithine in the Treatment of African Trypanosomiasis. Systematic Review
por: Hidalgo, Jessica, et al.
Publicado: (2021)

A multicentre, randomised, non-inferiority clinical trial comparing a nifurtimox-eflornithine combination to standard eflornithine monotherapy for late stage Trypanosoma brucei gambiense human African trypanosomiasis in Uganda
por: Kansiime, Freddie, et al.
Publicado: (2018)

Untargeted Metabolomics Reveals a Lack Of Synergy between Nifurtimox and Eflornithine against Trypanosoma brucei
por: Vincent, Isabel M., et al.
Publicado: (2012)

Prescription of concomitant medications in patients treated with Nifurtimox Eflornithine Combination Therapy (NECT) for T.b. gambiense second stage sleeping sickness in the Democratic Republic of the Congo
por: Kuemmerle, Andrea, et al.
Publicado: (2020)

Effectiveness of Nifurtimox Eflornithine Combination Therapy (NECT) in T. b. gambiense second stage sleeping sickness patients in the Democratic Republic of Congo: Report from a field study
por: Kuemmerle, Andrea, et al.
Publicado: (2021)

Genome-wide RNAi screens in African trypanosomes identify the nifurtimox activator NTR and the eflornithine transporter AAT6
por: Baker, Nicola, et al.
Publicado: (2011)

The Unknown Risk of Vertical Transmission in Sleeping Sickness—A Literature Review
por: Lindner, Andreas K., et al.
Publicado: (2010)

Enantiospecific antitrypanosomal in vitro activity of eflornithine
por: Boberg, Mikael, et al.
Publicado: (2021)

Prevalence and under-detection of gambiense human African trypanosomiasis during mass screening sessions in Uganda and Sudan
por: Checchi, Francesco, et al.
Publicado: (2012)

Estimates of the duration of the early and late stage of gambiense sleeping sickness
por: Checchi, Francesco, et al.
Publicado: (2008)

"Sleeping Sickness" in Uganda
Publicado: (1902)

Sleeping Sickness in Uganda
por: Greig, E. D. W.
Publicado: (1910)

The Sleeping Sickness of Uganda
Publicado: (1903)

Sleeping Sickness in Uganda
por: Greig, E. D. W.
Publicado: (1906)

Nifurtimox Inhibits the Progression of Neuroblastoma in vivo
por: Kong, Eryan, et al.
Publicado: (2019)

A Molecular Mechanism for Eflornithine Resistance in African Trypanosomes
por: Vincent, Isabel M., et al.
Publicado: (2010)

NECT Is Next: Implementing the New Drug Combination Therapy for Trypanosoma brucei gambiense Sleeping Sickness
por: Yun, Oliver, et al.
Publicado: (2010)

3,3'-Diindolylmethane plus Eflornithine suppress DNA Replication and Cell Cycle in Esophageal Squamous Cell Carcinoma in vivo
por: Ma, Fayang, et al.
Publicado: (2022)

Clinical importance of eflornithine (α-difluoromethylornithine) for the treatment of malignant gliomas
por: Levin, Victor A, et al.
Publicado: (2018)

Structural and Mechanistic Investigation of the Unusual Metabolism of Nifurtimox
por: Lang, Dieter, et al.
Publicado: (2022)

Lantern Demonstration of "Sleeping Sickness in Uganda"
por: Greig, E. D. W.
Publicado: (1906)

Correction to “Structural and Mechanistic Investigation of the Unusual Metabolism of Nifurtimox”
por: Lang, Dieter, et al.
Publicado: (2023)

Trypanososma brucei rhodesiense Sleeping Sickness, Uganda
por: Berrang-Ford, Lea, et al.
Publicado: (2012)

Effect of eflornithine on mutation frequency in temozolomide-treated U87MG cells
por: Yam, Noymi, et al.
Publicado: (2020)

Safety and efficacy of hydroxyurea and eflornithine against most blood parasites Babesia and Theileria
por: El-Saber Batiha, Gaber, et al.
Publicado: (2020)

Application of Hantzsch reaction for sensitive determination of eflornithine in cream, plasma and urine samples
por: Almahri, Albandary, et al.
Publicado: (2021)

Safety Profile of Nifurtimox for Treatment of Chagas Disease in the United States
por: Forsyth, Colin J., et al.
Publicado: (2016)

Tolerance to nifurtimox and benznidazole in adult patients with chronic Chagas’ disease
por: Jackson, Yves, et al.
Publicado: (2020)

Solid Nanomedicines of Nifurtimox and Benznidazole for the Oral Treatment of Chagas Disease
por: Rolon, Miriam, et al.
Publicado: (2022)

Accuracy of Five Algorithms to Diagnose Gambiense Human African Trypanosomiasis
por: Checchi, Francesco, et al.
Publicado: (2011)

Eflornithine Hydrochloride-Loaded Electrospun Nanofibers as a Potential Face Mask for Hirsutism Application
por: Almuwallad, Shuruq S., et al.
Publicado: (2023)

Late Stage Infection in Sleeping Sickness
por: Wolburg, Hartwig, et al.
Publicado: (2012)

Recommendations for Control of East African Sleeping Sickness in Uganda
por: Kotlyar, Simon
Publicado: (2010)

Genotoxicity Revaluation of Three Commercial Nitroheterocyclic Drugs: Nifurtimox, Benznidazole, and Metronidazole
por: Buschini, Annamaria, et al.
Publicado: (2009)

Nifurtimox Is Effective Against Neural Tumor Cells and Is Synergistic with Buthionine Sulfoximine
por: Du, Michael, et al.
Publicado: (2016)

The Natural Progression of Gambiense Sleeping Sickness: What Is the Evidence?
por: Checchi, Francesco, et al.
Publicado: (2008)

Chiral Chromatographic Isolation on Milligram Scale of the Human African Trypanosomiasis Treatment d- and l-Eflornithine
por: Boberg, Mikael, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_u03b9hfs9vcstrb0kcqiuc1or7